Product Images Eplerenone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Eplerenone NDC 66993-343 by Prasco Laboratories, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Eplerenone Structural Formula - eplernone tablets 1
Figure 1. Kaplan-Meier Estimates of All-Cause Mortality - eplernone tablets 2
This seems to be a statistical output of a clinical trial evaluating the use of a drug called Eplerenone with a sample size of 6632 (3313 taking Placbo and 3319 taking Eplerenone). The numbers in the first few lines indicate some percentages, but it isn't clear what they are referring to. The rest of the text shows the number of participants at risk over a period of 27 months since the start of the study. It also gives the value of p and RR for the drug. There isn't enough context provided to draw any further conclusions.*
Figure 2. Hazard Ratios of All-Cause Mortality by Subgroups - eplernone tablets 3
This appears to be a table indicating different patient groups based on their medical conditions and treatment options. The table includes different categories such as "Non-Diabetic," "Diabetic with CHF," and "Diabetic without CHF," as well as additional information about factors like the patient's creatinine clearance rate (CrCl) and whether they are being treated with certain medications like beta blockers or ACE inhibitors. The table also includes information on whether the patient is taking digoxin and appears to evaluate the efficacy of a drug called Eplerenone compared to a placebo. However, without additional information, it is difficult to determine the specific context or purpose of this table.*
Figure 3. Eplerenone Dose Response – Trough Cuff SBP Placebo-Subtracted Adjusted Mean Change from Baseline in Hypertension Studies - eplernone tablets 4
This appears to be a table or chart giving information about the reduction in 5BF (measured in mmHg) for various dosages of the drug Eplerenone in different studies. The dosages listed are 100 and 150 mg/day and the studies are labeled "Study 1QD," "Study 2 QD," and "Study 2 BID." No further details or context are provided.*
Figure 4. Eplerenone Dose Response – Trough Cuff DBP Placebo-Subtracted Adjusted Mean Change from Baseline in Hypertension Studies - eplernone tablets 5
25mg label 30ct - eplernone tablets 6
Each film-coated tablet contains Eplerenone in mg strength. The usual dosage information is provided separately. It is advised to keep the medication out of reach of children and store it at 20-25°C. The tablets are manufactured in India by a company named Asco LLC. The product is available in a pack of 30 tablets and is available only with a prescription. The tablets must be dispensed in a tightly closed, light-resistant container with a child-resistant closure, as defined in the USP. There is no other information available.*
50mg label 30ct - eplernone tablets 7
25mg label 90ct - eplernone tablets 8
Each tablet coated with Eplerenone 25mg, manufactured for Prasco LLC, Mason, OH, USA, and made in India. The recommended dosage is enclosed in the prescription information. It is suggested to store it at 20 to 25-degree Celsius. This medication contains 90 tablets. Dispense it in a firmly closed, light-resistant container with a child-proof lid. Keep it away from children. No other information is available.*
50mg label 90ct - eplernone tablets 9
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.